These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17675339)

  • 41. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
    Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis.
    Schneider Y; Duranton B; Gossé F; Schleiffer R; Seiler N; Raul F
    Nutr Cancer; 2001; 39(1):102-7. PubMed ID: 11588890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cells.
    Weng YL; Liao HF; Li AF; Chang JC; Chiou RY
    Mol Nutr Food Res; 2010 Feb; 54(2):259-67. PubMed ID: 19862773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resveratrol: a candidate nutritional substance for prostate cancer prevention.
    Stewart JR; Artime MC; O'Brian CA
    J Nutr; 2003 Jul; 133(7 Suppl):2440S-2443S. PubMed ID: 12840221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
    Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
    Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resveratrol--a prostate cancer chemopreventive agent?
    Ratan HL; Steward WP; Gescher AJ; Mellon JK
    Urol Oncol; 2002; 7(6):223-7. PubMed ID: 12504842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of SV-40 Tag rats as a model to study prostate cancer.
    Harper CE; Patel BB; Cook LM; Wang J; Shirai T; Eltoum IA; Lamartiniere CA
    BMC Cancer; 2009 Jan; 9():30. PubMed ID: 19171036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice.
    Lin X; Gingrich JR; Bao W; Li J; Haroon ZA; Demark-Wahnefried W
    Urology; 2002 Nov; 60(5):919-24. PubMed ID: 12429338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol and derivatives for the prevention and treatment of cancer.
    Fulda S
    Drug Discov Today; 2010 Sep; 15(17-18):757-65. PubMed ID: 20692359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
    Kumar A; Rimando AM; Levenson AS
    Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model.
    Busquets S; Ametller E; Fuster G; Olivan M; Raab V; Argilés JM; López-Soriano FJ
    Cancer Lett; 2007 Jan; 245(1-2):144-8. PubMed ID: 16466851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Resveratrol and newly synthetized resveratrol analogs in therapy of prostate carcinoma].
    Djavan B; Marihart S; Kuehhas F; Rom M; Partin A; Schalken J; Sekeres T
    Urologe A; 2007 Sep; 46(9):1101-3. PubMed ID: 17690863
    [No Abstract]   [Full Text] [Related]  

  • 54. The basis for the chemopreventive action of resveratrol.
    Roemer K; Mahyar-Roemer M
    Drugs Today (Barc); 2002 Aug; 38(8):571-80. PubMed ID: 12582422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways.
    Klink JC; Tewari AK; Masko EM; Antonelli J; Febbo PG; Cohen P; Dewhirst MW; Pizzo SV; Freedland SJ
    Prostate; 2013 May; 73(7):754-62. PubMed ID: 23192356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resveratrol and propolis extract: an insight into the morphological and molecular changes induced in DU145 cells.
    Scifo C; Milasi A; Guarnera A; Sinatra F; Renis M
    Oncol Res; 2006; 15(9):409-21. PubMed ID: 16555547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genotoxicity study of resveratrol in primary gastric adenocarcinoma cell cultures.
    Mitruţ P; Burada F; Enescu A; Scorei R; Badea D; Genunche-Dumitrescu A; Rogoz I; Manea M
    Rom J Morphol Embryol; 2009; 50(3):429-33. PubMed ID: 19690770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemopreventive effects of resveratrol and resveratrol derivatives.
    Szekeres T; Saiko P; Fritzer-Szekeres M; Djavan B; Jäger W
    Ann N Y Acad Sci; 2011 Jan; 1215():89-95. PubMed ID: 21261645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genistein chemoprevention of prostate cancer in TRAMP mice.
    Wang J; Eltoum IE; Lamartiniere CA
    J Carcinog; 2007 Mar; 6():3. PubMed ID: 17367528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model.
    Gray A; Aronson WJ; Barnard RJ; Mehta H; Wan J; Said J; Cohen P; Galet C
    J Endocrinol; 2011 Dec; 211(3):297-304. PubMed ID: 21903863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.